parkinson-s disease

AI-DBS study: protocol for a longitudinal prospective observational cohort study of patients with Parkinson’s disease for the development of neuronal fingerprints using artificial intelligence
Mariëlle J Stam, Martijn G J de Neeling, Bart J Keulen, Deborah Hubers, Rob M A de Bie, Rick Schuurman, Arthur W G Buijink, Bernadette C M van Wijk, Martijn Beudel

BMJ Open May 2025, 15 (5) e091563; DOI: 10.1136/bmjopen-2024-091563
Evaluating the occupation-based complex intervention for living well with anxiety and Parkinson’s disease (OBtAIN-PD) in community rehabilitation teams in the UK: a feasibility cluster randomised controlled trial protocol
Chris Lovegrove, Katrina Bannigan, Christopher Hayward, Wendy Ingram, Matthew Peter Bailey, Paigan Aspinall, Joanne Hosking, Ingrid Sturkenboom, Jonathan Marsden

BMJ Open Apr 2025, 15 (4) e079803; DOI: 10.1136/bmjopen-2023-079803
Non-invasive device to alleviate symptoms in people living with Parkinson’s: study protocol for a multicentre phase II double-blind randomised controlled trial
Viktoria Azoidou, Essa Bhadra, Kira Rowsell, Ellen Camboe, Kamalesh Dey, Alexandra Zirra, Corrine Quah, Caroline Budu, Thomas Boyle, David Gallagher, Alastair Noyce, Cristina Simonet

BMJ Open Apr 2025, 15 (4) e096051; DOI: 10.1136/bmjopen-2024-096051
Impact of hypersexuality on spousal carers of patients with Parkinson’s disease and frontotemporal dementia: a qualitative study
Natalie Tayim, Jalesh Panicker, Jennifer Foley, Caroline Selai, Walaa G El Sheikh

BMJ Open Apr 2025, 15 (4) e090870; DOI: 10.1136/bmjopen-2024-090870
Can behavioural science be used to understand factors that influence the prescription choice for Parkinson’s disease? A pan-European focus group study of clinicians’ prescribing practice
Emma Begley, Jason Michael Thomas, William Hind, Carl Senior

BMJ Open Feb 2025, 15 (2) e090018; DOI: 10.1136/bmjopen-2024-090018
Exploring how PRIME-Parkinson care is implemented and whether, how and why it produces change, for who and under what conditions: a protocol for an embedded process evaluation within the PRIME-UK randomised controlled trial
Katherine Lloyd, Emma Tenison, Safi Smith, Fiona Lithander, Judi Kidger, Heather Brant, Sabi Redwood, Yoav Ben-Shlomo, Emily J Henderson

BMJ Open Jan 2025, 15 (1) e086353; DOI: 10.1136/bmjopen-2024-086353
Digital health technologies and self-efficacy in Parkinson’s: a scoping review
Andrew Michael Hall, Victoria Allgar, Camille B Carroll, Edward Meinert

BMJ Open Jan 2025, 15 (1) e088616; DOI: 10.1136/bmjopen-2024-088616
Living with pain and Parkinson’s developing an understanding of the impact, trajectory and pain management needs: a qualitative interview study protocol
Jenni Naisby, Leah Avery, Katherine Baker, Mark Parkinson, Annette Hand, Lynn Rochester, Alison Yarnall, Richard Walker, Darren Flynn, Cormac Ryan, Tracy Finch

BMJ Open Dec 2024, 14 (12) e078754; DOI: 10.1136/bmjopen-2023-078754
Efficacy and long-term effects of the intervention of Zhan Zhuang Qigong on Pisa syndrome in Parkinson’s disease: the study protocol for a randomised control trial
Linlin Zhang, Yuxiao Chen, Yuqi Zhang, Xiaoming Xi, Hongyan Bi, Pujian Chen, Fen Chen, Cheng Wang, Bin Huang

BMJ Open Oct 2024, 14 (10) e084418; DOI: 10.1136/bmjopen-2024-084418
Study protocol of the HessenKohorte2042: a prospective, longitudinal cohort study characterising quality of life in people with Parkinson’s disease and their caregivers using a bio-psycho-social approach
Urs Kleinholdermann, Franziska Thieken, Marina Christine Ruppert-Junck, Marlena van Munster, Anna Julia Pedrosa, Johanne Stümpel, Vincent Hammes, Lars Timmermann, Christiane Woopen, Björn Schmitz-Luhn, Anna Storms, Heidrun Golla, Urs M Nater, Nadine Skoluda, Petra Ina Pfefferle, David José Pedrosa

BMJ Open Jul 2024, 14 (7) e080475; DOI: 10.1136/bmjopen-2023-080475

Main menu

parkinson-s disease

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

parkinson-s disease

Pages